{"content":"<li class=\"n-box-item date-title\" data-end=\"1483592399\" data-start=\"1483506000\" data-txt=\"Sunday, December 22, 2019\">Wednesday, January  4, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3233556\" data-ts=\"1483587477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233556-aeterna-zentaris-says-macrilen-phase-3-trial-failed-to-achieve-objective\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeterna Zentaris says Macrilen Phase 3 trial failed to achieve objective</a></h4><ul>     <li>Aeterna Zentaris (NASDAQ:<a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a>) <font color='red'>-38.3%</font> AH after reporting that the confirmatory Phase 3 clinical trial of Macrilen <a href=\"http://www.businesswire.com/news/home/20170104006480/en/Aeterna-Zentaris-Announces-Top-Line-Results-Confirmatory-Phase\" target=\"_blank\">failed to achieve its objective</a> of validating a single oral dose of macimorelin for the evaluation of growth hormone deficiency in adults.</li>     <li>AEZS says it is evaluating the outcome of the trial and will determine in the near future whether it will continue with the development of Macrilen.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233556\" data-linked=\"Aeterna Zentaris says Macrilen Phase 3 trial failed to achieve objective\" data-tweet=\"$AEZS - Aeterna Zentaris says Macrilen Phase 3 trial failed to achieve objective https://seekingalpha.com/news/3233556-aeterna-zentaris-says-macrilen-phase-3-trial-failed-to-achieve-objective?source=tweet\" data-url=\"https://seekingalpha.com/news/3233556-aeterna-zentaris-says-macrilen-phase-3-trial-failed-to-achieve-objective\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233553\" data-ts=\"1483573316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNCRY\" target=\"_blank\">KNCRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233553-terex-to-redeem-notes-to-lower-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Terex to redeem notes to lower debt</a></h4><ul>   <li>Terex (<a href='https://seekingalpha.com/symbol/TEX' title='Terex Corporation'>TEX</a> <font color='green'>+1.8%</font>) has said it will <a href=\"https://seekingalpha.com/pr/16705525-terex-corporation-announces-300-million-partial-redemption-6-percent-senior-notes-due-2021\" target=\"_blank\">redeem $300M</a> of an outstanding $850M in 6% senior notes due 2021.</li>    <li>The company's redeeming at 103% of principal amount, plus accrued and unpaid interest.</li>    <li>It also said it plans to retire all $300M of its 6.5% senior notes due 2020, at a redemption price of 101.625% on April 3.</li>    <li>The moves are \"consistent with our previously stated intention to reduce our total debt and improve our balance sheet,\" says CEO John Garrison.</li>    <li>Earlier, the company said it wrapped the sale of its <a href=\"https://seekingalpha.com/pr/16705214-terex-completes-sale-material-handling-port-solutions-business\" target=\"_blank\">Material Handling and Port Solutions business</a> to Konecranes (<a href='https://seekingalpha.com/symbol/KNCRY' title='Konecranes Plc ADR'>OTCPK:KNCRY</a>), for $595M and &euro;200M in cash along with 25% of Konecranes (about 19.6M newly issued class B shares).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233553\" data-linked=\"Terex to redeem notes to lower debt\" data-tweet=\"$KNCRY $KNCRY $TEX - Terex to redeem notes to lower debt https://seekingalpha.com/news/3233553-terex-to-redeem-notes-to-lower-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3233553-terex-to-redeem-notes-to-lower-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233551\" data-ts=\"1483572932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MC\" target=\"_blank\">MC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233551-moelis-co-launches-5m-share-offering-to-boost-public-float\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moelis &amp; Co. launches 5M-share offering to boost public float</a></h4><ul>   <li>Investment bank Moelis &amp; Co. (<a href='https://seekingalpha.com/symbol/MC' title='Moelis & Company'>MC</a> <font color='green'>+2.7%</font>) is <font color='red'>off 4%</font> after hours as it launches a <a href=\"https://seekingalpha.com/pr/16705446-moelis-and-company-commences-public-offering-class-common-stock\" target=\"_blank\">public offering of common stock</a>.</li>    <li>The number of fully diluted shares outstanding won't increase, however. The company will offer 5M shares of class A common stock, with a 30-day greenshoe option to buy up to 750,000 shares more.</li>    <li>It will use proceeds to repurchase the same number of shares from some of the company's managing directors and former employees. It says it's conducting the offering to \"facilitate organized liquidity in its Class A common stock and to increase the public float of its Class A common stock.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233551\" data-linked=\"Moelis &amp; Co. launches 5M-share offering to boost public float\" data-tweet=\"$MC - Moelis &amp; Co. launches 5M-share offering to boost public float https://seekingalpha.com/news/3233551-moelis-co-launches-5m-share-offering-to-boost-public-float?source=tweet\" data-url=\"https://seekingalpha.com/news/3233551-moelis-co-launches-5m-share-offering-to-boost-public-float\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233548\" data-ts=\"1483571091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233548-late-season-football-leads-nbc-espn-to-easy-ratings-wins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Late-season football leads NBC, ESPN to easy ratings wins</a></h4><ul>   <li>Football again drove weekly TV ratings and pushed NBC (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+1.2%</font>) to its <a href=\"http://www.seattletimes.com/business/football-carried-nbc-espn-to-big-wins-in-audience-last-week/\" target=\"_blank\">sixth straight weekly win</a>, a streak it hasn't mustered in 21 years.</li>    <li>Meanwhile on the cable side, key college bowl games led ESPN (<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='green'>+1.3%</font>) to a runaway victory. The sports network averaged 8.38M viewers in prime time, far ahead of Fox News (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+0.9%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+1%</font>) with 1.86M and Hallmark with 1.73M. The pregame and game broadcast for the championship semifinal of Washington vs. Alabama were second and fourth among individual programs, with 18.9M and 18.4M viewers respectively.</li>    <li>Overall, ESPN college football programs took six of the top 10 ratings slots, with pro football on NBC taking another three. CBS (<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> <font color='green'>+2.1%</font>) newsmagazine <i>60 Minutes</i> was 10th with 11.72M viewers, edging out ABC's 10 p.m. hour of <i>New Year's Rockin' Eve</i> (11.56M).</li>    <li>In broadcast ratings, NBC averaged 6.21M viewers, ahead of CBS at 5.75M. ABC logged 4.14M viewers and Fox 3.2M.</li>    <li>ABC's <i>World News Tonight</i> took the nightly news lead with 8.95M viewers, ahead of <i>NBC Nightly News</i> with 8.8M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233548\" data-linked=\"Late-season football leads NBC, ESPN to easy ratings wins\" data-tweet=\"$FOX $FOX $FOXA - Late-season football leads NBC, ESPN to easy ratings wins https://seekingalpha.com/news/3233548-late-season-football-leads-nbc-espn-to-easy-ratings-wins?source=tweet\" data-url=\"https://seekingalpha.com/news/3233548-late-season-football-leads-nbc-espn-to-easy-ratings-wins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233545\" data-ts=\"1483569582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233545-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='green'>+2.8%</font>. <a href='https://seekingalpha.com/symbol/ACHC' title='Acadia Healthcare Co.'>ACHC</a> <font color='green'>+2.7%</font>. <a href='https://seekingalpha.com/symbol/HLT' title='Hilton Worldwide Holdings'>HLT</a> <font color='green'>+1.7%</font>. FSC <font color='green'>+1.1%</font>. <a href='https://seekingalpha.com/symbol/UAE' title='iShares MSCI UAE Capped ETF'>UAE</a> <font color='green'>+1.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='red'>-15.0%</font>. <a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='red'>-9.7%</font>. <a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='red'>-5.4%</font>. <a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-4.0%</font>. <a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a> <font color='red'>-3.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233545\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SGYP-OLD $ACHC $HLT - After Hours Gainers / Losers https://seekingalpha.com/news/3233545-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3233545-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233542\" data-ts=\"1483568464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLX\" target=\"_blank\">HLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233542-helix-energy-to-launch-21m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helix Energy to launch 21M-share offering</a></h4><ul>     <li>Helix Energy Solutions (NYSE:<a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a>) <font color='red'>-10.7%</font>&nbsp;AH after announcing a public offering of 21M common shares, with an underwriters option to purchase up to an additional 3.15M shares.</li>     <li>HLX says it plans to use the proceeds for general corporate purposes, which may include debt repayment, capex, working capital, acquisitions or investments in subsidiaries.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233542\" data-linked=\"Helix Energy to launch 21M-share offering\" data-tweet=\"$HLX - Helix Energy to launch 21M-share offering https://seekingalpha.com/news/3233542-helix-energy-to-launch-21m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3233542-helix-energy-to-launch-21m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233538\" data-ts=\"1483567600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233538-arena-bails-on-selling-belviq-transfers-remaining-commercialization-rights-to-eisai-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arena bails on selling Belviq, transfers remaining commercialization rights to Eisai; shares up 8% after hours</a></h4><ul><li>Arena Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARNA' title='Arena Pharmaceuticals, Inc.'>ARNA</a>) perks up&nbsp;<font color='green'>8%</font>&nbsp;after hours on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16705347-arena-pharmaceuticals-eisai-amend-marketing-supply-agreement-belviq-globally\" target=\"_blank\">announcement </a>that it has amended its BELVIQ (lorcaserin HCl) marketing and supply agreement with Eisai (<a href='https://seekingalpha.com/symbol/ESALY' title='Eisai Co., Ltd. ADR'>OTCPK:ESALY</a>). Under the revised contract, Eisai will have global commercialization rights including the territories retained by Arena (South Korea, Taiwan, Australia, Israel and New Zealand) under the companies' <a href=\"http://invest.arenapharm.com/releasedetail.cfm?releaseid=805598\" target=\"_blank\">November 2013 deal</a>.</li><li>Eisai will have complete responsibility for all lorcaserin development expenses going forward while Arena will continue to receive royalties on BELVIQ net sales. Arena will continue to manufacture product at its facility in Switzerland.</li><li>Under the terms of the revised agreement, Arena will receive $23M in cash payments and over $80M in potential cost relief on current lorcaserin development obligations. The company says the transition will enable it to concentrate its resources on its clinical-stage programs.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233538\" data-linked=\"Arena bails on selling Belviq, transfers remaining commercialization rights to Eisai; shares up 8% after hours\" data-tweet=\"$ARNA $ARNA $ESALY - Arena bails on selling Belviq, transfers remaining commercialization rights to Eisai; shares up 8% after hours https://seekingalpha.com/news/3233538-arena-bails-on-selling-belviq-transfers-remaining-commercialization-rights-to-eisai-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3233538-arena-bails-on-selling-belviq-transfers-remaining-commercialization-rights-to-eisai-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233537\" data-ts=\"1483567590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233537-retail-names-reeling-after-warnings-from-macys-kohls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail names reeling after warnings from Macy&#39;s, Kohl&#39;s</a></h4><ul>     <li>Shares of traditional department stores <a href=\"http://www.marketwatch.com/story/department-store-shares-sell-off-after-kohls-macys-reports-2017-01-04\" target=\"_blank\">tumble after-hours</a> as Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) and Kohl's (NYSE:<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a>) cut earnings estimates due to weak holiday sales (<a href=\"https://seekingalpha.com/news/3233519-macys-cuts-profit-guidance-details-store-closings\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/news/3233530-kohls-minus-13-percent-ah-following-reduced-earnings-guidance-lower-comp-sales\" target=\"_blank\">II</a>); Macy's also added details on its previous announcement to close 100  stores, saying the moves will result in 10K job cuts and a $575M reduction in 2017 sales.</li>     <li>The news causes a ripple effect across the sector: <a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='red'>-5.9%</font>, <a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-4.8%</font>, <a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a> <font color='red'>-3.4%</font>, SHLD <font color='red'>-2.5%</font>, <a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-1.8%</font>, <a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a> <font color='red'>-1.5%</font> AH.</li>     <li>Apparel and accessory  companies with significant presences in big box retail also are lower: KORS <font color='red'>-2.8%</font>, COH <font color='red'>-2.6%</font>, <a href='https://seekingalpha.com/symbol/KATE' title='Kate Spade & Company'>KATE</a> <font color='red'>-1.1%</font> AH.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLY' title='Consumer Discretionary Select Sector SPDR ETF'>XLY</a>, <a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>, <a href='https://seekingalpha.com/symbol/VCR' title='Vanguard Consumer Discretionary ETF'>VCR</a>, <a href='https://seekingalpha.com/symbol/RTH' title='VanEck Vectors Retail ETF'>RTH</a>, <a href='https://seekingalpha.com/symbol/RETL' title='Direxion Daily Retail Bull 3x Shares ETF'>RETL</a>, <a href='https://seekingalpha.com/symbol/FXD' title='First Trust Consumer Discretionary AlphaDEX ETF'>FXD</a>, <a href='https://seekingalpha.com/symbol/FDIS' title='Fidelity MSCI Consumer Discretionary Index ETF'>FDIS</a>, <a href='https://seekingalpha.com/symbol/RCD' title='Invesco S&P Equal Weight Consumer Discretionary ETF'>RCD</a>, <a href='https://seekingalpha.com/symbol/PMR' title='Invesco Dynamic Retail Portfolio ETF'>PMR</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3233537\" data-linked=\"Retail names reeling after warnings from Macy&#39;s, Kohl&#39;s\" data-tweet=\"$M $M $KSS - Retail names reeling after warnings from Macy&#39;s, Kohl&#39;s https://seekingalpha.com/news/3233537-retail-names-reeling-after-warnings-from-macys-kohls?source=tweet\" data-url=\"https://seekingalpha.com/news/3233537-retail-names-reeling-after-warnings-from-macys-kohls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233530\" data-ts=\"1483566503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSS\" target=\"_blank\">KSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233530-kohlsminus-13-ah-following-reduced-earnings-guidance-lower-comp-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kohl&#39;s -13% AH following reduced earnings guidance, lower comp sales</a></h4><ul>     <li>Kohl&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a>) <font color='red'>-13.2%</font>&nbsp;AH after <a href=\"https://seekingalpha.com/pr/16705299-kohls-corporation-reports-november-december-sales-updates-2016-guidance\" target=\"_blank\">cutting FY 2017 earnings guidance</a> below Wall Street expectations, after Q4 sales came in worse than expected.</li>     <li>KSS now sees EPS of $3.60-$3.65 from $3.80-$4.00 previously and below $3.93 analyst consensus estimate, as comparable sales fell 2.1% Y/Y in the fiscal months of November and December 2016 combined.</li>     <li>Total sales for the two months tumbled 2.7%, with the company citing lower than expected gross margins due to the mix and timing of the sales and the competitive promotional environment.</li>     <li>KSS says sales were volatile throughout the holiday season, with strong sales on Black Friday and during the week before Christmas offset by softness in early November and December.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233530\" data-linked=\"Kohl&#39;s -13% AH following reduced earnings guidance, lower comp sales\" data-tweet=\"$KSS - Kohl&#39;s -13% AH following reduced earnings guidance, lower comp sales https://seekingalpha.com/news/3233530-kohlsminus-13-ah-following-reduced-earnings-guidance-lower-comp-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3233530-kohlsminus-13-ah-following-reduced-earnings-guidance-lower-comp-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233525\" data-ts=\"1483566199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233525-heron-therapeutics-pain-candidate-htxminus-011-shows-positive-effect-in-mid-stage-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron Therapeutics&#39; pain candidate HTX-011 shows positive effect in mid-stage studies; shares down 8% after hours on soft Sustol guidance</a></h4><ul><li>Heron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a>) slumps&nbsp;<font color='red'>8%</font>&nbsp;after hours on robust volume despite its <a href=\"https://seekingalpha.com/pr/16705333-heron-therapeutics-announces-positive-topline-results-phase-2-clinical-trial-htxminus-011\" target=\"_blank\">announcement </a>of positive results from two Phase 2 clinical trials, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02689258?term=htx-011&amp;phase=1&amp;rank=2\" target=\"_blank\">Study 203</a> and <a href=\"https://clinicaltrials.gov/ct2/show/NCT02762929?term=htx-011&amp;phase=1&amp;rank=3\" target=\"_blank\">Study 208</a>, assessing HTX-011 for the management of post-operative pain following abdominoplasty (tummy tuck).</li><li>Top-line showed treatment with HTX-011 statistically significantly reduced both pain intensity and the use of opioid rescue medications through 96 hours after surgery compared to placebo.</li><li><a href=\"https://seekingalpha.com/pr/16705331-heron-therapeutics-establishes-synergy-bupivacaine-meloxicam-htxminus-011-prevention-post\" target=\"_blank\">Results </a>from Study 208 demonstrated the synergy between bupivacaine, a local anesthetic, and meloxicam, a non-steroidal anti-inflammatory drug, in patients undergoing bunionectomy. The combination showed a statistically significant analgesic benefit over each individual drug alone.</li><li><a href=\"http://www.herontx.com/HTX-011\" target=\"_blank\">HTX-011</a>&nbsp;is an injectable formulation based on the company's&nbsp;<a href=\"http://www.herontx.com/our-technologies\" target=\"_blank\">Bichronomer&nbsp;polymer-based drug delivery platform</a>&nbsp;which enables the release of bupivacaine and meloxicam over an extended period.</li><li>The company intends to meet with the FDA to review the data and initiate Phase 3 studies later this year. If all goes according to plan, it will file an NDA in 2018.</li><li>Management will host a conference call tomorrow, January 5, at 8:30 am ET to discuss the results.</li><li>Shares are slumping due to the company's <a href=\"https://www.sec.gov/Archives/edgar/data/818033/000119312517001819/d325812dex993.htm\" target=\"_blank\">forecast </a>(slide #7) of Sustol sales this year, $15M - 25M, well below the consensus of $50M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233525\" data-linked=\"Heron Therapeutics&#39; pain candidate HTX-011 shows positive effect in mid-stage studies; shares down 8% after hours on soft Sustol guidance\" data-tweet=\"$HRTX - Heron Therapeutics&#39; pain candidate HTX-011 shows positive effect in mid-stage studies; shares down 8% after hours on soft Sustol guidance https://seekingalpha.com/news/3233525-heron-therapeutics-pain-candidate-htxminus-011-shows-positive-effect-in-mid-stage-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3233525-heron-therapeutics-pain-candidate-htxminus-011-shows-positive-effect-in-mid-stage-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233524\" data-ts=\"1483565757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNOP\" target=\"_blank\">KNOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233524-knot-offshore-partners-to-launch-2_5m-unit-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KNOT Offshore Partners to launch 2.5M-unit offering</a></h4><ul><li>KNOT Offshore Partners (NYSE:<a href='https://seekingalpha.com/symbol/KNOP' title='KNOT Offshore Partners LP'>KNOP</a>) <font color='red'>-3.5%</font>&nbsp;AH after announcing a <a href=\"https://seekingalpha.com/pr/16705385-knot-offshore-partners-lp-announces-public-offering-2500-000-common-units\" target=\"_blank\">public offering</a> of 2.5M common units, with an underwriters option to purchase up to an additional 375K units.</li><li>KNOP says it plans to use the proceeds for general  partnership purposes, which may include paying down debt and funding working capital, capex or  acquisitions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233524\" data-linked=\"KNOT Offshore Partners to launch 2.5M-unit offering\" data-tweet=\"$KNOP - KNOT Offshore Partners to launch 2.5M-unit offering https://seekingalpha.com/news/3233524-knot-offshore-partners-to-launch-2_5m-unit-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3233524-knot-offshore-partners-to-launch-2_5m-unit-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233519\" data-ts=\"1483564830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233519-macys-cuts-profit-guidance-details-store-closings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s cuts profit guidance, details store closings</a></h4><ul>     <li>Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) maintains guidance for 2.5% to 3.0% sales growth in 2016. Comparable sales on an owned plus licensed basis fell 2.1% for the holiday period.</li>     <li>The company lowers it view on 2016 EPS to $2.95-$3.10 vs. $3.15-$3.40 prior.</li>     <li>In a separate announcement, the company details store closures, reorganizations measures and job eliminations. The 68 stores to be shuttered are part of the 100 closings previously announced.</li>     <li>M&nbsp;<font color='red'>-5.60%</font>&nbsp;AH to $33.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233519\" data-linked=\"Macy&#39;s cuts profit guidance, details store closings\" data-tweet=\"$M - Macy&#39;s cuts profit guidance, details store closings https://seekingalpha.com/news/3233519-macys-cuts-profit-guidance-details-store-closings?source=tweet\" data-url=\"https://seekingalpha.com/news/3233519-macys-cuts-profit-guidance-details-store-closings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233509\" data-ts=\"1483563980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233509-sonic-beats-0_03-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic beats by $0.03, misses on revenue</a></h4><ul><li>Sonic (NASDAQ:<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a>): FQ1 EPS of $0.24 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $129.56M (-11.1% Y/Y) <font color='red'>misses by $1.14M</font>.</li><li>Shares <font color='green'>+3.25%</font>.</li><li><a href='https://seekingalpha.com/pr/16705352-sonic-refranchising-momentum-continues-first-fiscal-quarter'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3233509\" data-linked=\"Sonic beats by $0.03, misses on revenue\" data-tweet=\"$SONC - Sonic beats by $0.03, misses on revenue https://seekingalpha.com/news/3233509-sonic-beats-0_03-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3233509-sonic-beats-0_03-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233508\" data-ts=\"1483563498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNI\" target=\"_blank\">CNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233508-canadian-national-rail-upgraded-raymond-james\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian National Rail upgraded at Raymond James</a></h4><ul>     <li>Canadian National Railway (<a href='https://seekingalpha.com/symbol/CNI' title='Canadian National Railway Company'>CNI</a> <font color='green'>+2.3%</font>) is <a href=\"http://business.financialpost.com/investing/trading-desk/cn-rail-upgraded-but-attractive-entry-point-seen-in-cp-rail\" target=\"_blank\">upgraded</a> to Outperform from Market Perform with a $104 price target, up from $94, at Raymond James, which also maintains its Outperform rating and $230 target on Canadian Pacific Railway (<a href='https://seekingalpha.com/symbol/CP' title='Canadian Pacific Railway Limited'>CP</a> <font color='green'>+3.2%</font>).</li>     <li>While improved Canadian rail traffic in Q4 helped both companies, James analyst Steve Hansen says CNI is &ldquo;strongly outperforming,&rdquo; as the company repatriates grain volumes that reportedly were lost in the previous year; he also highlights CP&rsquo;s crude-by-rail portfolio, which saw a sharp decline in Q4 traffic.</li>     <li>However, Hansen expects bulk commodities such as grain, potash and coal will regain momentum, and outsized headwinds such as crude-by-rail to become less of a drag.</li>     <li>&ldquo;Looking forward, while CN and CP both stand to benefit from the positive macro backdrop described, we are increasingly mindful of CP&rsquo;s widening discount/valuation gap versus CN... therefore presenting an increasingly attractive entry point for long-term investors,&rdquo; Hansen writes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233508\" data-linked=\"Canadian National Rail upgraded at Raymond James\" data-tweet=\"$CNI $CNI $CP - Canadian National Rail upgraded at Raymond James https://seekingalpha.com/news/3233508-canadian-national-rail-upgraded-raymond-james?source=tweet\" data-url=\"https://seekingalpha.com/news/3233508-canadian-national-rail-upgraded-raymond-james\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233504\" data-ts=\"1483562246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233504-valero-downgraded-hollyfrontier-upgraded-deutsche-bank\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valero downgraded, HollyFrontier upgraded at Deutsche Bank</a></h4><ul>     <li>Valero Energy (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='red'>-3.6%</font>) is sharply lower after Deutsche Bank <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Downgrades+Valero+Energy+%28VLO%29+to+Hold/12388315.html\" target=\"_blank\">downgrades</a> shares to Hold from Buy with a $65 price target, while HollyFrontier (<a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corp.'>HFC</a> <font color='green'>+2.2%</font>) is higher following the firm's <a href=\"http://www.streetinsider.com/Analyst+Comments/Deutsche+Bank+Upgrades+HollyFrontier+%28HFC%29+to+Buy/12388309.html\" target=\"_blank\">upgrade to Buy</a> from Hold with a $38 target, raised from $30.</li>     <li>Deutsche Bank says VLO remains a fundamentally strong operator with sustainably strong capture rates, but shares are fully valued current levels, trading at a historically premium 7.1x forward EBITDA, which would more than fully price in a full repeal of RINs expenses and corporate tax reform, two major tailwinds for the refinery sector in 2017.</li>     <li>On HFC, the firm sees attractive leverage to key themes for the group. including RINs relief, corporate tax cuts, widening of narrow inland differentials and limited exposure to potential import/export border tax adjustments.</li><li>Refiners are mostly lower in today's trade: TSO <font color='red'>-3.2%</font>, <a href='https://seekingalpha.com/symbol/PSX' title='Phillips 66'>PSX</a> <font color='green'>+0.7%</font>, <a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corp.'>MPC</a> <font color='red'>-2.7%</font>, <a href='https://seekingalpha.com/symbol/WNR' title='Western Refining, Inc.'>WNR</a> <font color='red'>-3.2%</font>, <a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy'>PBF</a> <font color='red'>-4.9%</font>, <a href='https://seekingalpha.com/symbol/CVI' title='CVR Energy, Inc.'>CVI</a> <font color='green'>+0.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233504\" data-linked=\"Valero downgraded, HollyFrontier upgraded at Deutsche Bank\" data-tweet=\"$VLO $VLO $HFC - Valero downgraded, HollyFrontier upgraded at Deutsche Bank https://seekingalpha.com/news/3233504-valero-downgraded-hollyfrontier-upgraded-deutsche-bank?source=tweet\" data-url=\"https://seekingalpha.com/news/3233504-valero-downgraded-hollyfrontier-upgraded-deutsche-bank\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233501\" data-ts=\"1483561601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233501-deutsche-bank-financial-crime-chief-exits-after-6-months\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank financial crime chief exits after 6 months</a></h4><ul><li>Peter Hazlewodd, was hired to help shore up systems and controls at the oft-investigated Deutsche Bank (NYSE:<a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a>), is stepping down, <a href=\"https://www.ft.com/content/6dece652-d270-11e6-9341-7393bb2e1b51\" target=\"_blank\">reports the <em>FT</em></a>. He's likely to move to another position at the bank.</li><li>The speed of his exit suggests a \"clash of styles,\" says Atlantic Equiites' Chris Wheeler.</li><li>The stock, meanwhile, is enjoying a big day,&nbsp;<font color='green'>up 6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233501\" data-linked=\"Deutsche Bank financial crime chief exits after 6 months\" data-tweet=\"$DB - Deutsche Bank financial crime chief exits after 6 months https://seekingalpha.com/news/3233501-deutsche-bank-financial-crime-chief-exits-after-6-months?source=tweet\" data-url=\"https://seekingalpha.com/news/3233501-deutsche-bank-financial-crime-chief-exits-after-6-months\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233503\" data-ts=\"1483561143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233503-freeport-mcmoran-powers-higher-up-12-in-two-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport McMoRan powers higher, up 12% in two days</a></h4><ul>     <li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+7.1%</font>) catches a bid this afternoon and is now up more than 12% in two days, as investors appear to favor the stock's potential to benefit from economic and political catalysts during a Trump presidency.</li><li>FCX yesterday announced the <a href=\"http://www.oilandgas360.com/elk-petroleum-acquire-freeport-mcmorans-wyoming-gas-co2-production-assets/\" target=\"_blank\">sale</a> of another group of oil and gas assets, this time its interests in two Wyoming gas fields and CO2 production assets to Australia's Elk Petroleum for $20M.</li>     <li>Jefferies yesterday reiterated its <a href=\"http://www.streetinsider.com/Analyst+Comments/Jefferies+Reiterates+Buy+on+Freeport-McMoran+%28FCX%29/12383309.html\" target=\"_blank\">Buy recommendation</a> for FCX, as the company discusses mining rights at Grasberg and exports of unprocessed concentrates after Jan. 11 with Indonesia.</li>     <li>Posting at Seeking Alpha, The Value Portfolio and Alpha Investor both like FCX's outlook (<a href=\"https://seekingalpha.com/article/4034210-freeport-mcmoran-significant-potential\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/article/4033356-will-freeport-mcmoran-continue-winner-next-year\" target=\"_blank\">II</a>), citing the company's impressive asset portfolio and decreasing debt load.</li>     <li>However, Jim Cramer is <a href=\"https://www.thestreet.com/story/13941102/1/cramer-freeport-mcmoran-might-have-run-out-of-gas.html\" target=\"_blank\">not hot for the stock</a> after nearly doubling last year, saying \" FCX might have gone about as far as it can go without help from worldwide GDP growth.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233503\" data-linked=\"Freeport McMoRan powers higher, up 12% in two days\" data-tweet=\"$FCX - Freeport McMoRan powers higher, up 12% in two days https://seekingalpha.com/news/3233503-freeport-mcmoran-powers-higher-up-12-in-two-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3233503-freeport-mcmoran-powers-higher-up-12-in-two-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233497\" data-ts=\"1483560000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233497-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OIIM' title='O2Micro International Limited'>OIIM</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/EMAN' title='eMagin Corporation'>EMAN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CRNT' title='Ceragon Networks Ltd.'>CRNT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/INVE' title='Identiv, Inc.'>INVE</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/NIHD' title='NII Holdings, Inc.'>NIHD</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> MSDI <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FNCX' title='Function&#40;x&#41; Inc.'>OTC:FNCX</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233497\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$OIIM $EMAN $CRNT - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3233497-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3233497-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233496\" data-ts=\"1483559950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDT\" target=\"_blank\">IDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233496-net2phone-acquires-liveninja-to-beef-up-smb-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Net2phone acquires LiveNinja to beef up SMB offering</a></h4><ul>   <li>Unified communications provider Net2phone (<a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a> <font color='green'>+1.8%</font>) has <a href=\"https://seekingalpha.com/pr/16705022-net2phone-acquires-liveninja\" target=\"_blank\">acquired LiveNinja</a>, a customer-facing service that it will integrate into its own offerings.</li>    <li>Net2phone will combine LiveNinja's customer messaging and live chat service with PicuP, which gives small/mid-size businesses a self-service platform to deal with inbound calls, including auto-attendants, customized welcomes and voicemail to e-mail.</li>    <li>LiveNinja will continue to offer its platform on a stand-alone basis until integration of services is complete; then LiveNinja's customers will be transitioned to PicuP.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233496\" data-linked=\"Net2phone acquires LiveNinja to beef up SMB offering\" data-tweet=\"$IDT - Net2phone acquires LiveNinja to beef up SMB offering https://seekingalpha.com/news/3233496-net2phone-acquires-liveninja-to-beef-up-smb-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3233496-net2phone-acquires-liveninja-to-beef-up-smb-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233494\" data-ts=\"1483559324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBR\" target=\"_blank\">NBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233494-nabors-superior-energy-precision-drilling-patterson-upped-credit-suisse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nabors, Superior Energy, Precision Drilling, Patterson upped at Credit Suisse</a></h4><ul>     <li>Credit Suisse analyst James Wichlund <a href=\"http://www.streetinsider.com/Analyst+Comments/Credit+Suisse+Upgrades+Oilfield+Services+%26+Equipment+Sector+Along+With+%28SPN%29%2C+%28NBR%29%2C+%28PTEN%29%2C+And+%28PDS%29%2C+Downgrades+%28BHI%29/12388096.html\" target=\"_blank\">upgrades the oilfield services and equipment sector</a> and select names, citing seasonal and cyclical recovery trade for 2017.</li>     <li>Oilfield services stocks are not cheap on any 2018 valuation metric, Wichlund says, but he expects to see upward earnings revisions beginning in Q1 and continue for the next few years - the opposite of the past two years of downward earnings revisions - and thinks management teams will underpromise and over-deliver on pricing and utilization gains as the cycle turns.</li>     <li>The firm upgrades Nabors Industries (<a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color='green'>+3.8%</font>) and Superior Energy (<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color='green'>+5%</font>) to Outperform from Neutral, and raises Precision Drilling (<a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color='green'>+5.2%</font>) and Patterson-UTI (<a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a> <font color='green'>+2.9%</font>) to Neutral from Underperform, while cutting Baker Hughes (BHI <font color='green'>+0.1%</font>) to Neutral from Outperform, citing a \"significantly disconnected\" valuation from business fundamentals.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/IEZ' title='iShares U.S. Oil Equipment & Services ETF'>IEZ</a>, <a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3233494\" data-linked=\"Nabors, Superior Energy, Precision Drilling, Patterson upped at Credit Suisse\" data-tweet=\"$NBR $NBR $SPN - Nabors, Superior Energy, Precision Drilling, Patterson upped at Credit Suisse https://seekingalpha.com/news/3233494-nabors-superior-energy-precision-drilling-patterson-upped-credit-suisse?source=tweet\" data-url=\"https://seekingalpha.com/news/3233494-nabors-superior-energy-precision-drilling-patterson-upped-credit-suisse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233492\" data-ts=\"1483558499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233492-activisionplus-2_1-amid-mixed-analyst-sentiments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activision +2.1% amid mixed analyst sentiments</a></h4><ul>   <li>Activision Blizzard (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>) is <font color='green'>up 2.1%</font> and reclaiming its mid-December levels after Piper Jaffray added the firm to its top picks list for 2017.</li>    <li>Fast-growing services revenue is a key driver, Piper says, noting that \"viewing of video game content has exploded in recent years and with a push by various companies, such as Activision, into e-sports, we expect online viewing of recorded and live game play will grow substantially in 2017.\"</li>    <li>Meanwhile, Cowen is cutting estimates on the belief that the newest <i>Call of Duty</i> entry has sold even fewer units than originally projected. The firm also expects no new release in fiscal 2017 from the Blizzard unit, pointing to silence since November's annual fan convention.</li>    <li>Cowen cut its fiscal 2017 EPS estimate by 16%, to $1.82, vs. consensus for $2.13.</li>    <li>\"While the stock is likely to confront an earnings overhang in the immediate term, we think a better outlook for FY18 will eventually get shares moving higher again,\" Cowen says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233492\" data-linked=\"Activision +2.1% amid mixed analyst sentiments\" data-tweet=\"$ATVI - Activision +2.1% amid mixed analyst sentiments https://seekingalpha.com/news/3233492-activisionplus-2_1-amid-mixed-analyst-sentiments?source=tweet\" data-url=\"https://seekingalpha.com/news/3233492-activisionplus-2_1-amid-mixed-analyst-sentiments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233486\" data-ts=\"1483556662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233486-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CLMT' title='Calumet Specialty Products Partners, L.P.'>CLMT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='green'>+8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3233486\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$LEU $VHI $PQ - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3233486-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3233486-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233484\" data-ts=\"1483556370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233484-hulu-confirms-deal-for-rights-to-live-cbs-broadcast-two-networks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hulu confirms deal for rights to live CBS broadcast, two other networks</a></h4><ul>   <li>Hulu has confirmed it's <a href=\"https://seekingalpha.com/pr/16705156-hulu-inks-agreement-cbs-corporation-add-leading-networks-upcoming-live-tv-service\" target=\"_blank\">signed a licensing agreement</a> with CBS (<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> <font color='green'>+2.1%</font>), to carry the CBS broadcast network along with CBS Sports Network and POP, on its forthcoming live streaming TV service.</li>    <li>That doesn't include the full complement of networks that many expected (for example, it leaves out the CW and Smithsonian), though Hulu (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+0.9%</font>; <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='green'>+1.1%</font>; <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+0.6%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+0.6%</font>; <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a> <font color='green'>+0.3%</font>) says the deal has the potential to add additional networks in the future.</li>    <li>Much of the programming will not only be available live but also on demand, though CBS will retain full-season stacking for its own CBS All Access service.</li>    <li>The two already have a deal to offer Showtime as premium add-on; the new deal extends that arrangement.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233445-wsj-hulu-cbs-announce-live-service-carriage-deal-cbs-plus-3_1-percent\" target=\"_blank\">WSJ: Hulu, CBS to announce live-service carriage deal; CBS +3.1%</a> (Jan. 04 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233484\" data-linked=\"Hulu confirms deal for rights to live CBS broadcast, two other networks\" data-tweet=\"$CMCSA $CMCSA $DIS - Hulu confirms deal for rights to live CBS broadcast, two other networks https://seekingalpha.com/news/3233484-hulu-confirms-deal-for-rights-to-live-cbs-broadcast-two-networks?source=tweet\" data-url=\"https://seekingalpha.com/news/3233484-hulu-confirms-deal-for-rights-to-live-cbs-broadcast-two-networks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233483\" data-ts=\"1483556270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233483-hospital-stocks-party-orderly-dismantling-of-obamacare-proceeds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hospital stocks party as &quot;orderly&quot; dismantling of Obamacare proceeds</a></h4><ul><li>The Senate minutes ago voted (along party lines) to proceed to consideration of a budget resolution that would pave the way for an up/down vote on repealing large parts of the law.</li><li>House Speaker Paul Ryan and Vice President-elect Mike Pence both promise a stable and \"orderly transition\" through both executive and legislative action to repeal and replace ACA.</li><li>Among the movers: Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+7.5%</font>), Kindred Healthcare (<a href='https://seekingalpha.com/symbol/KND' title='Kindred Healthcare, Inc.'>KND</a> <font color='green'>+7.1%</font>), Quorum Health (<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+9.8%</font>), Community Health (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+6.5%</font>)</li><li><a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>&nbsp;<font color='green'>+0.6%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>, <a href='https://seekingalpha.com/symbol/IYH' title='iShares U.S. Healthcare ETF'>IYH</a>, <a href='https://seekingalpha.com/symbol/VHT' title='Vanguard Health Care ETF'>VHT</a>, <a href='https://seekingalpha.com/symbol/HQH' title='Tekla Healthcare Investors'>HQH</a>, <a href='https://seekingalpha.com/symbol/CURE' title='Direxion Daily Healthcare Bull 3x Shares ETF'>CURE</a>, <a href='https://seekingalpha.com/symbol/FXH' title='First Trust Health Care AlphaDEX ETF'>FXH</a>, <a href='https://seekingalpha.com/symbol/FHLC' title='Fidelity MSCI Health Care Index ETF'>FHLC</a>, <a href='https://seekingalpha.com/symbol/RXL' title='ProShares Ultra Health Care ETF'>RXL</a>, <a href='https://seekingalpha.com/symbol/THQ' title='Tekla Healthcare Opportunities Fund'>THQ</a>, <a href='https://seekingalpha.com/symbol/RYH' title='Invesco S&P Equal Weight Health Care ETF'>RYH</a>, <a href='https://seekingalpha.com/symbol/RXD' title='ProShares UltraShort Health Care ETF'>RXD</a>, <a href='https://seekingalpha.com/symbol/SICK' title='Daily Healthcare Bear 3x Shares ETF'>SICK</a>, <a href='https://seekingalpha.com/symbol/BTEC' title='Principal Healthcare Innovators Index ETF'>BTEC</a>, <a href='https://seekingalpha.com/symbol/HCRF' title='iShares Edge MSCI Multifactor Healthcare ETF'>HCRF</a>, <a href='https://seekingalpha.com/symbol/JHMH' title='John Hancock Multifactor Healthcare ETF'>JHMH</a>, <a href='https://seekingalpha.com/symbol/LNGR' title='Global X Longevity Thematic ETF'>LNGR</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3233483\" data-linked=\"Hospital stocks party as &quot;orderly&quot; dismantling of Obamacare proceeds\" data-tweet=\"$THC $THC $KND - Hospital stocks party as &quot;orderly&quot; dismantling of Obamacare proceeds https://seekingalpha.com/news/3233483-hospital-stocks-party-orderly-dismantling-of-obamacare-proceeds?source=tweet\" data-url=\"https://seekingalpha.com/news/3233483-hospital-stocks-party-orderly-dismantling-of-obamacare-proceeds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233482\" data-ts=\"1483556242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAI\" target=\"_blank\">RAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233482-mega-tobacco-merger-reportedly-in-jeopardy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mega-tobacco merger reportedly in jeopardy</a></h4><ul><li>Deal talks on a proposed takeover of Reynolds American (<a href='https://seekingalpha.com/symbol/RAI' title='Reynolds American, Inc.'>RAI</a> <font color='red'>-1.4%</font>) by British American Tobacco (<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c. &#40;American Depository Receipts&#41;'>BTI</a> <font color='red'>-0.3%</font>) have hit a snag, according to a <a href=\"http://www.streetinsider.com/Hot+M+and+A/BAT+%28BTI%29%2C+Reynolds+%28RAI%29+Deal+Said+to+Hit+a+Snag+-+Source/12390519.html\" target=\"_blank\">report</a> posted on StreetInsider.com citing sources.</li><li>Shares of Reynolds are down on the day, but off their low point of the session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233482\" data-linked=\"Mega-tobacco merger reportedly in jeopardy\" data-tweet=\"$RAI $RAI $BTI - Mega-tobacco merger reportedly in jeopardy https://seekingalpha.com/news/3233482-mega-tobacco-merger-reportedly-in-jeopardy?source=tweet\" data-url=\"https://seekingalpha.com/news/3233482-mega-tobacco-merger-reportedly-in-jeopardy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233478\" data-ts=\"1483555400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKT\" target=\"_blank\">SKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233478-mall-reits-get-sell-side-love\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mall REITs get some sell-side love</a></h4><ul><li>Skipping neutral, Jefferies analyst&nbsp;Omotayo Okusanya lifts his view of the sector to positive from negative thanks to the potential for better economic growth under the incoming administration.</li><li>Tanger Factory (<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color='green'>+2.6%</font>) is lifted to Buy from Hold, and Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='green'>+0.3%</font>) and CBL (<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='green'>+2.2%</font>) are named as top picks.</li><li>He calls the holiday shopping season \"solid,\" and sees a potentially improved retail sales environment this year, with store closings moderating. Sears, though, is the \"wild card,\" given its potential bankruptcy.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233346-sears-exiting-19-seritage-properties\" target=\"_blank\">Sears exiting 19 Seritage properties</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3233478\" data-linked=\"Mall REITs get some sell-side love\" data-tweet=\"$SKT $SKT $SPG - Mall REITs get some sell-side love https://seekingalpha.com/news/3233478-mall-reits-get-sell-side-love?source=tweet\" data-url=\"https://seekingalpha.com/news/3233478-mall-reits-get-sell-side-love\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233474\" data-ts=\"1483554672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233474-fitbit-partners-habit-peloton-virzoom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit partners with Habit, Peloton, VirZOOM</a></h4><ul><li>With <a href=\"https://habit.com\" target=\"_blank\">Habit</a> on custom food recommendations and nutrition plans, <a href=\"https://www.pelotoncycle.com\" target=\"_blank\">Peloton</a> on post-ride metric sharing and <a href=\"https://www.virzoom.com/\" target=\"_blank\">VirZOOM</a> on VR bike riding. [<a href=\"https://seekingalpha.com/pr/16704590-fitbit-now-integrates-innovative-brands-habit-peloton-virzoom\" target=\"_blank\">press release</a>]</li><li>Fitbit yesterday additionally disclosed the first custom feature developed for the Charge 2 through integration with the UnitedHealthcare Motion wellness program, powered by Qualcomm Life. [<a href=\"https://seekingalpha.com/pr/16702995-fitbit-announces-integration-qualcomm-life-s-2net-platform-help-unitedhealthcare-motion\" target=\"_blank\">press release</a>]</li><li>Shares (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>) today&nbsp;<font color='green'>+5.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233474\" data-linked=\"Fitbit partners with Habit, Peloton, VirZOOM\" data-tweet=\"$FIT - Fitbit partners with Habit, Peloton, VirZOOM https://seekingalpha.com/news/3233474-fitbit-partners-habit-peloton-virzoom?source=tweet\" data-url=\"https://seekingalpha.com/news/3233474-fitbit-partners-habit-peloton-virzoom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233473\" data-ts=\"1483554505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TITXF\" target=\"_blank\">TITXF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233473-new-chief-titan-medical-shares-jump-45\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New chief at Titan Medical; shares jump 45%</a></h4><ul><li>Investors apparently love <a href=\"https://seekingalpha.com/pr/16702985-healthcare-industry-leader-david-j-mcnally-named-ceo-titan-medical-inc\" target=\"_blank\">David McNally</a>, the new CEO at Titan Medical (<a href='https://seekingalpha.com/symbol/TITXF' title='Titan Medical Inc.'>OTCQB:TITXF</a> <font color='green'>+44.6%</font>). Shares have doubled in two days on the expectation that his track record for building shareholder value will continue.</li><li>Previously, Mr. McNally founded Domain Surgical, which merged with OmniGuide in 2016, and co-founded ZEVEX International, acquired by Moog in 2007.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233473\" data-linked=\"New chief at Titan Medical; shares jump 45%\" data-tweet=\"$TITXF - New chief at Titan Medical; shares jump 45% https://seekingalpha.com/news/3233473-new-chief-titan-medical-shares-jump-45?source=tweet\" data-url=\"https://seekingalpha.com/news/3233473-new-chief-titan-medical-shares-jump-45\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233469\" data-ts=\"1483553707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBFX\" target=\"_blank\">PBFX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233469-pbf-logistics-guides-2017-earnings-revenues-above-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PBF Logistics guides 2017 earnings, revenues above consensus</a></h4><ul><li>PBF Logistics (<a href='https://seekingalpha.com/symbol/PBFX' title='PBF Logistics LP'>PBFX</a> <font color='green'>+2.9%</font>) is higher after guiding FY 2017 earnings and revenue above analyst consensus in <a href=\"https://www.sec.gov/Archives/edgar/data/1582568/000158256817000002/a20170103pbfjanuaryprese.htm\" target=\"_blank\">presentation slides</a> ahead of the Wolfe Research Refining Conference.</li><li>PBFX sees 2017 net income of ~$2.56/share, based off of 42.3M units outstanding, vs. $2.04 consensus, on revenues of $252M, vs $212M consensus.</li><li>PBFX also sees 2017 capex of $625M-$650M, with total throughput expected of 795K-845K bbl/day.</li><li>Also, <a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy'>PBF</a> <font color='red'>-4.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233469\" data-linked=\"PBF Logistics guides 2017 earnings, revenues above consensus\" data-tweet=\"$PBFX $PBFX $PBF - PBF Logistics guides 2017 earnings, revenues above consensus https://seekingalpha.com/news/3233469-pbf-logistics-guides-2017-earnings-revenues-above-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3233469-pbf-logistics-guides-2017-earnings-revenues-above-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233464\" data-ts=\"1483553095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELY\" target=\"_blank\">ELY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233464-big-bertha-buzz-takes-callaway-golf-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big Bertha buzz takes Callaway Golf higher</a></h4><ul><li>Callaway Golf (<a href='https://seekingalpha.com/symbol/ELY' title='Callaway Golf Company'>ELY</a> <font color='green'>+3.3%</font>) is&nbsp;<font color='green'>up 4%</font>&nbsp;on a move attributed to buzz over the new Great Big Bertha Epic drivers.</li><li>Golfwrx.com has one of the most <a href=\"http://www.golfwrx.com/420618/review-callaway-gbb-epic-and-epic-sub-zero-drivers/\" target=\"_blank\">extensive reviews</a> on the new clubs that can be found.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233464\" data-linked=\"Big Bertha buzz takes Callaway Golf higher\" data-tweet=\"$ELY - Big Bertha buzz takes Callaway Golf higher https://seekingalpha.com/news/3233464-big-bertha-buzz-takes-callaway-golf-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3233464-big-bertha-buzz-takes-callaway-golf-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233457\" data-ts=\"1483552838\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233457-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group'>PMTS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ONDK' title='OnDeck Capital'>ONDK</a> <font color='green'>+12%</font>. RAS <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group L.P.'>BX</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/COWN' title='Cowen Group, Inc.'>COWN</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='red'>-7%</font>. WMIH <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FRBK' title='Republic First Bancorp, Inc.'>FRBK</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233457\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$PMTS $ONDK $RASF - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3233457-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3233457-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233456\" data-ts=\"1483552465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233456-sarepta-on-rebound-shares-up-5-on-expectations-exondys-51-will-finally-start-to-ramp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta on the rebound? Shares up 5% on expectations that Exondys 51 will finally start to ramp</a></h4><ul><li>Beaten down Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+5%</font>) finally perks up. Shares had lost almost&nbsp;<font color='red'>60%</font>&nbsp;of their value since peaking when the FDA approved Duchenne muscular dystrophy &#40;DMD&#41; med Exondys 51 (eteplirsen) in September. Investors have been concerned about whether doctors will prescribe the drug and if insurers will pay for it.</li><li>Barron's Ben Levisohn reports that a <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/01/04/sarepta-therapeutics-slow-going/?mod=BOL_hp_blog_stw\" target=\"_blank\">survey </a>of 49 DMD specialists conducted by Morgan Stanley showed that they expect as many as 30% of available patients to be on the drug in the next three months and 75% by year end despite a very sluggish launch to date (only one patient currently being treated). The data suggests that demand will be driven by physicians as well as patients and the expected ramp-up will finally happen.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233456\" data-linked=\"Sarepta on the rebound? Shares up 5% on expectations that Exondys 51 will finally start to ramp\" data-tweet=\"$SRPT - Sarepta on the rebound? Shares up 5% on expectations that Exondys 51 will finally start to ramp https://seekingalpha.com/news/3233456-sarepta-on-rebound-shares-up-5-on-expectations-exondys-51-will-finally-start-to-ramp?source=tweet\" data-url=\"https://seekingalpha.com/news/3233456-sarepta-on-rebound-shares-up-5-on-expectations-exondys-51-will-finally-start-to-ramp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233460\" data-ts=\"1483552251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233460-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/OREX' title='Orexigen Therapeutics, Inc.'>OREX</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/MRUS' title='Merus'>MRUS</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/OIIM' title='O2Micro International Limited'>OIIM</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/EMAN' title='eMagin Corporation'>EMAN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/PHMD' title='PhotoMedex, Inc.'>PHMD</a> <font color='green'>+18%</font>.</li><li><b>Losers:&nbsp;</b><a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a> <font color='red'>-47%</font>. <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/PZRX' title='PhaseRx'>PZRX</a> <font color='red'>-8%</font>. SKLN <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='red'>-7%</font>. WMIH <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SBBP' title='Strongbridge Biopharma'>SBBP</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233460\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$OREX $CBAY $EVOK - Midday Gainers / Losers https://seekingalpha.com/news/3233460-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3233460-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233453\" data-ts=\"1483551598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233453-splunk-removed-from-downside-catalyst-watch-list-citi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk removed from downside catalyst watch list at Citi</a></h4><ul><li>Noting share underperformance since <a href=\"https://seekingalpha.com/news/3227488-splunk-plus-3_7-percent-q3-outlook-expectations\" target=\"_blank\">Q3 reporting</a>&nbsp;on concern FY 2018 would be guided below consensus, <a href=\"http://www.streetinsider.com/Analyst+Comments/Splunk+%28SPLK%29+Gains+as+Citi+Sees+Limited+Downside+from+Here/12389697.html\" target=\"_blank\">analyst Walter Pritchard</a>&nbsp;suggests \"limited downside from here\"&nbsp;for Splunk.</li><li>Shares (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>)&nbsp;<font color='green'>+5.62%&nbsp;</font>in today's session,&nbsp;<font color='red'>roughly 3%</font>&nbsp;lower than pre-earnings (November 29, 2016) levels.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233453\" data-linked=\"Splunk removed from downside catalyst watch list at Citi\" data-tweet=\"$SPLK - Splunk removed from downside catalyst watch list at Citi https://seekingalpha.com/news/3233453-splunk-removed-from-downside-catalyst-watch-list-citi?source=tweet\" data-url=\"https://seekingalpha.com/news/3233453-splunk-removed-from-downside-catalyst-watch-list-citi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233449\" data-ts=\"1483551020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWAGY\" target=\"_blank\">VWAGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233449-audi-december-u-s-salesplus-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Audi December U.S. sales: +14%</a></h4><ul>     <li>Audi (VLKAY) unit sales <a href=\"https://seekingalpha.com/pr/16705018-audi-breaks-annual-u-s-sales-record-210213-deliveries-suvs-set-pace\" target=\"_blank\">+13.7%</a> to 23,195 units.</li>     <li>Sales by model line: A3 -11% to 2,904; A4 +26% to 4,009; A5 -41% to 591; Q5 +6% to 6,396; Q3 +36% to 2,047.</li>     <li>2016 Audi sales +4.0% to 210,213 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233449\" data-linked=\"Audi December U.S. sales: +14%\" data-tweet=\"$VWAGY - Audi December U.S. sales: +14% https://seekingalpha.com/news/3233449-audi-december-u-s-salesplus-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3233449-audi-december-u-s-salesplus-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233445\" data-ts=\"1483549917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233445-wsj-hulu-cbs-to-announce-live-service-carriage-deal-cbsplus-3_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Hulu, CBS to announce live-service carriage deal; CBS +3.1%</a></h4><ul>     <li>CBS (NYSE:<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>) and Hulu are expected to announce a deal today where the streaming service will license the CBS broadcast network and some of its cable nets for the <a href=\"http://www.wsj.com/articles/cbs-nearing-a-deal-with-hulu-for-live-streaming-service-1483549218\" target=\"_blank\">planned Hulu live TV service</a>, <i>The Wall Street Journal</i> reports.</li>     <li>CBS shares have jumped in response, <font color='green'>up 3.1%</font>.</li>     <li>The deal is said to cover only the live service, not Hulu's existing on-demand offering. Full current seasons of popular CBS shows on demand would remain exclusive to CBS' own streaming service, CBS All Access. But Hulu will get a few recent episodes of such shows, and CBS will bring in more than $3 per monthly subscriber in the deal at first.</li>     <li>Eventually in the long-term deal, though, CBS could get more than $4 per monthly sub -- more than what it makes from existing pay TV distributors.</li>     <li>Hulu -- co-owned by CBS rivals Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>), Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>), Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) and Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>) -- has already signed other major groups including owners Disney, Fox and Time Warner.</li>   <li><b>Updated 12:14 p.m.:</b> Hulu owners' stocks are on the move: <a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='green'>+1.6%</font>; <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='green'>+0.8%</font>; <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+1%</font>; <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+1.1%</font>; <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a> <font color='green'>+0.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233445\" data-linked=\"WSJ: Hulu, CBS to announce live-service carriage deal; CBS +3.1%\" data-tweet=\"$CBS $VIAC $CMCSA - WSJ: Hulu, CBS to announce live-service carriage deal; CBS +3.1% https://seekingalpha.com/news/3233445-wsj-hulu-cbs-to-announce-live-service-carriage-deal-cbsplus-3_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3233445-wsj-hulu-cbs-to-announce-live-service-carriage-deal-cbsplus-3_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233444\" data-ts=\"1483549595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPMX\" target=\"_blank\">BPMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233444-biopharmx-completes-enrollment-in-mid-stage-study-of-acne-treatment-bpxminus-01-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioPharmX completes enrollment in mid-stage study of acne treatment BPX-01; shares up 5%</a></h4><ul><li>BioPharmX (<a href='https://seekingalpha.com/symbol/BPMX' title='BioPharmX Corporation'>BPMX</a> <font color='green'>+4.6%</font>) hits the <a href=\"https://seekingalpha.com/pr/16704746-biopharmx-completes-enrollment-bpxminus-01-phase-2b-opal-clinical-trial-acne-vulgaris\" target=\"_blank\">enrollment target</a> in its Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02815332?term=bpx-01&amp;rank=2\" target=\"_blank\">OPAL</a>, assessing BPX-01 for the treatment of moderate-to-severe inflammatory, non-nodular acne vulgaris. The primary endpoint is the absolute mean change from baseline in inflammatory lesion count at week 12. Top-line data should be available in H1. Results will inform the design of a Phase 3 study.</li><li><a href=\"http://www.biopharmx.com/products/#pipeline\" target=\"_blank\">BPX-01</a> is a fully solubilized, non-oily topical minocycline gel. The formulation delivers the antibiotic directly to the source of acne while avoiding systemic exposure. High doses of oral minocycline are associated with unwanted side effects including nausea, sensitivity to sunlight, skin rash, itching and discoloration of the gums, skin or nails.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233444\" data-linked=\"BioPharmX completes enrollment in mid-stage study of acne treatment BPX-01; shares up 5%\" data-tweet=\"$BPMX - BioPharmX completes enrollment in mid-stage study of acne treatment BPX-01; shares up 5% https://seekingalpha.com/news/3233444-biopharmx-completes-enrollment-in-mid-stage-study-of-acne-treatment-bpxminus-01-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3233444-biopharmx-completes-enrollment-in-mid-stage-study-of-acne-treatment-bpxminus-01-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233443\" data-ts=\"1483549366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFT\" target=\"_blank\">DFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233443-dupont-fabros-begins-building-another-chicago-area-data-center\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DuPont Fabros begins building another Chicago-area data center</a></h4><ul>   <li>DuPont Fabros Technology (<a href='https://seekingalpha.com/symbol/DFT' title='DuPont Fabros Technology'>DFT</a> <font color='green'>+2.9%</font>) has <a href=\"https://seekingalpha.com/pr/16704207-dupont-fabros-technology-inc-commences-development-ch3-data-center\" target=\"_blank\">launched development</a> of its CH3 data center in Elk Grove Village, Ill.</li>    <li>&ldquo;We believe demand in the Chicago market remains strong,&rdquo; CEO Christopher Eldredge says.</li>    <li>The first phase of construction will offer 12.8 MW of available critical load, set for delivery in Q1 2018. The completed center will comprise 25.6 MW of available critical load, 305,000 gross square feet and 160,000 computer room square feet.</li>    <li>Meanwhile, shares are up to their highest point since August. They're <font color='green'>up 19%</font> since Nov. 17.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233443\" data-linked=\"DuPont Fabros begins building another Chicago-area data center\" data-tweet=\"$DFT - DuPont Fabros begins building another Chicago-area data center https://seekingalpha.com/news/3233443-dupont-fabros-begins-building-another-chicago-area-data-center?source=tweet\" data-url=\"https://seekingalpha.com/news/3233443-dupont-fabros-begins-building-another-chicago-area-data-center\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233437\" data-ts=\"1483549290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233437-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/WILC' title='G. Willi-Food International, Ltd.'>WILC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MSN' title='Emerson Radio Corp'>MSN</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SQBG' title='Sequential Brands Group, Inc.'>SQBG</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/ACAT' title='Arctic Cat Inc.'>ACAT</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233437\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SEED $WILC $MSN - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3233437-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3233437-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233435\" data-ts=\"1483548337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233435-coca-cola-sued-over-marketing-claims\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coca-Cola sued over marketing claims</a></h4><ul><li>Coca-Cola (<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a> <font color='red'>-0.2%</font>) and the American Beverage Association have been <a href=\"https://cspinet.org/news/coca-cola-american-beverage-association-are-targets-lawsuit-charging-deceptive-sugary-drink\" target=\"_blank\">sued</a> in federal court over deceptive claims on the health risks posed by soda drinks.</li><li>Nonprofit Praxis Project is the plaintiff in the case.</li><li><a href=\"https://cspinet.org/sites/default/files/attachment/coca%20cola%20complaint.pdf\" target=\"_blank\">Full complaint</a> (.pdf)</li><li>Shares of Coca-Cola are at their session low.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233435\" data-linked=\"Coca-Cola sued over marketing claims\" data-tweet=\"$KO - Coca-Cola sued over marketing claims https://seekingalpha.com/news/3233435-coca-cola-sued-over-marketing-claims?source=tweet\" data-url=\"https://seekingalpha.com/news/3233435-coca-cola-sued-over-marketing-claims\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233434\" data-ts=\"1483548109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233434-pandora-rolling-out-new-ad-formats-after-successful-trials\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora rolling out new ad formats after successful trials</a></h4><ul>   <li>Pandora (<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='green'>+1.8%</font>) is launching <a href=\"https://seekingalpha.com/pr/16704723-pandora-roll-muted-video-responsive-display-ads-advertisers\" target=\"_blank\">two new ad formats</a> on Jan. 19.</li>    <li>The new offerings -- Muted Video and Responsive Mobile Display ads -- will go to all advertisers then after a pilot project launched in June to a few beta partners.</li>    <li>The ad formats will offer rich display and video ads in the space usually reserved for album art, and responsive design means that the ads will adjust seamlessly to a device's available screen size.</li>    <li>Beta partners saw up to 50% bumps in time spent with the Responsive Mobile Display ads. Advertisers using Muted Video saw a 32% increase in listeners who spend at least five seconds with the video.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233434\" data-linked=\"Pandora rolling out new ad formats after successful trials\" data-tweet=\"$P - Pandora rolling out new ad formats after successful trials https://seekingalpha.com/news/3233434-pandora-rolling-out-new-ad-formats-after-successful-trials?source=tweet\" data-url=\"https://seekingalpha.com/news/3233434-pandora-rolling-out-new-ad-formats-after-successful-trials\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233429\" data-ts=\"1483547686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ON\" target=\"_blank\">ON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233429-goldman-sachs-upgrades-on-semiconductor-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs upgrades ON Semiconductor to Buy</a></h4><ul><li>From Neutral, <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+ON+Semiconductor+%28ON%29+to+Buy%2C+%2415+PT/12388276.html\" target=\"_blank\">analyst Mark Delaney</a> expects outperformance on 29% EPS CAGR over the upcoming two years generated by product cycles (ADAS, wireless charging, PC power management)&nbsp;and margin expansion. Additionally observes indications of industrial market improvement.</li><li>Raises target from $12 to $15.</li><li>Shares (NASDAQ:<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a>)&nbsp;<font color='green'>+2.48%&nbsp;</font>to $13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233429\" data-linked=\"Goldman Sachs upgrades ON Semiconductor to Buy\" data-tweet=\"$ON - Goldman Sachs upgrades ON Semiconductor to Buy https://seekingalpha.com/news/3233429-goldman-sachs-upgrades-on-semiconductor-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3233429-goldman-sachs-upgrades-on-semiconductor-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233424\" data-ts=\"1483546874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233424-battery-production-starts-gigafactory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Battery production starts at the Gigafactory</a></h4><ul><li>Tesla Motors (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) says the first battery cells are being produced at the Gigafactory site in Nevada.</li><li>The initial battery cells are for the energy storage business, with the Model 3 production ramp still to come.</li><li>The company expects to have 6.5K employees at the Gigafactory by 2018, up from a current level of 2.9K.</li><li>Shares of Tesla are&nbsp;<font color='green'>up 3.50%</font>&nbsp;as investors cruise right past the 2016 deliveries miss announced yesterday.</li><li>Sources: Bloomberg and Tesla IR site.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233230-tesla-motors-misses-2016-delivery-guidance\" target=\"_blank\">Tesla Motors misses 2016 delivery guidance</a> (Jan. 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233378-tesla-motors-spotlight-deliveries-update\" target=\"_blank\">Tesla Motors in the spotlight after deliveries update</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3233424\" data-linked=\"Battery production starts at the Gigafactory\" data-tweet=\"$TSLA - Battery production starts at the Gigafactory https://seekingalpha.com/news/3233424-battery-production-starts-gigafactory?source=tweet\" data-url=\"https://seekingalpha.com/news/3233424-battery-production-starts-gigafactory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>93&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233423\" data-ts=\"1483546788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233423-acadiaplus-7_5-on-unconfirmed-takeover-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia +7.5% on unconfirmed takeover chatter</a></h4><ul><li>Source: <a href=\"http://www.streetinsider.com/Rumors/Acadia+Pharma+%28ACAD%29+on+Watch+Amid+Unconfirmed+Takeover+Rumors/12389920.html\" target=\"_blank\">StreetInsider</a></li><li><a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a>&nbsp;<font color='green'>+7.5%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3233423\" data-linked=\"Acadia +7.5% on unconfirmed takeover chatter\" data-tweet=\"$ACAD - Acadia +7.5% on unconfirmed takeover chatter https://seekingalpha.com/news/3233423-acadiaplus-7_5-on-unconfirmed-takeover-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3233423-acadiaplus-7_5-on-unconfirmed-takeover-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233420\" data-ts=\"1483546750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OREX\" target=\"_blank\">OREX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233420-orexigen-kicks-off-national-ad-campaign-supporting-contrave-shares-up-39\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orexigen kicks off national ad campaign supporting Contrave; shares up 39%</a></h4><ul><li>Investors clearly like the rationale of Orexigen Therapeutics' (<a href='https://seekingalpha.com/symbol/OREX' title='Orexigen Therapeutics, Inc.'>OREX</a> <font color='green'>+38.6%</font>) national direct-to-consumer <a href=\"https://seekingalpha.com/pr/16704005-orexigen-therapeutics-launches-brains-behind-weight-loss-dynamic-patient-focused-campaign\" target=\"_blank\">ad campaign </a>supporting weight loss pill CONTRAVE (naltrexone HCl/bupropion HCl). The campaign, \"Brains Behind Weigh Loss,\" is designed to show patients the important role the brain plays in weight loss. It started airing several days ago.</li><li>Shares are up almost&nbsp;<font color='green'>70%</font>&nbsp;since yesterday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233420\" data-linked=\"Orexigen kicks off national ad campaign supporting Contrave; shares up 39%\" data-tweet=\"$OREX - Orexigen kicks off national ad campaign supporting Contrave; shares up 39% https://seekingalpha.com/news/3233420-orexigen-kicks-off-national-ad-campaign-supporting-contrave-shares-up-39?source=tweet\" data-url=\"https://seekingalpha.com/news/3233420-orexigen-kicks-off-national-ad-campaign-supporting-contrave-shares-up-39\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233390\" data-ts=\"1483545693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233390-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OREX' title='Orexigen Therapeutics, Inc.'>OREX</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/PHMD' title='PhotoMedex, Inc.'>PHMD</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/MRUS' title='Merus'>MRUS</a> <font color='green'>+20%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a> <font color='red'>-51%</font>. <a href='https://seekingalpha.com/symbol/IART' title='Integra LifeSciences Holdings Corporation'>IART</a> <font color='red'>-49%</font>. <a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a> <font color='red'>-14%</font>. SKLN <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233390\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$OREX $CBAY $EVOK - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3233390-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3233390-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233412\" data-ts=\"1483545170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233412-hertz-global-rallies-after-gamco-boosts-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz Global rallies after Gamco boosts stake</a></h4><ul><li>Hertz Global (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='green'>+8.4%</font>) pops after Gamco reports it increased its stake to 5.1% from a prior position of 2.5%.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/807249/000080724917000001/htz_00.htm\" target=\"_blank\">SEC Form 13D</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3233412\" data-linked=\"Hertz Global rallies after Gamco boosts stake\" data-tweet=\"$HTZ - Hertz Global rallies after Gamco boosts stake https://seekingalpha.com/news/3233412-hertz-global-rallies-after-gamco-boosts-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3233412-hertz-global-rallies-after-gamco-boosts-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233410\" data-ts=\"1483544849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTW\" target=\"_blank\">WTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233410-weight-watchers-soars-amid-positive-developments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weight Watchers soars amid positive developments</a></h4><ul><li>Weight Watchers (NYSE:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>) is&nbsp;<font color='green'>up 14%</font>&nbsp;on strong volume to reach a six-month high.</li><li>It's unclear if investors are paying attention, but the Weight Watchers diet plan ranked 4th out of 38 diet plans <a href=\"http://health.usnews.com/wellness/food/slideshows/us-news-38-best-diets-overall?slide=8\" target=\"_blank\">evaluated</a> by U.S. News and World Report.</li><li>The publication called the Weight Watchers diet plan a \"smart\" and effective\" way to lose weight safely.</li><li>There's also a new <a href=\"https://twitter.com/Oprah/status/816403790387507202\" target=\"_blank\">tweet</a> from Oprah to factor in today and a price target bump from Sidoti ($28 from $25).</li></ul><div class=\"tiny-share-widget\" data-id=\"3233410\" data-linked=\"Weight Watchers soars amid positive developments\" data-tweet=\"$WTW $WW - Weight Watchers soars amid positive developments https://seekingalpha.com/news/3233410-weight-watchers-soars-amid-positive-developments?source=tweet\" data-url=\"https://seekingalpha.com/news/3233410-weight-watchers-soars-amid-positive-developments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233404\" data-ts=\"1483544219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGXT\" target=\"_blank\">IGXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233404-intelgenx-inks-deal-chemo-group-to-co-develop-generic-cns-med-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IntelGenx inks deal with Chemo group to co-develop generic CNS med; shares up 6%</a></h4><ul><li>IntelGenx (<a href='https://seekingalpha.com/symbol/IGXT' title='IntelGenx Technologies Corp.'>OTCQX:IGXT</a> <font color='green'>+6.1%</font>) enters into a global <a href=\"https://seekingalpha.com/pr/16704793-intelgenx-announces-definitive-agreement-chemo-group-generic-cns-tablet\" target=\"_blank\">agreement </a>with Chemo Group to co-develop and commercialize a generic tablet used in the CNS (central nervous system) area.</li><li>Under the terms of the deal, IntelGenx will receive an upfront payment, funds to pay development costs and milestones. The companies will share profits from commercialization.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233404\" data-linked=\"IntelGenx inks deal with Chemo group to co-develop generic CNS med; shares up 6%\" data-tweet=\"$IGXT - IntelGenx inks deal with Chemo group to co-develop generic CNS med; shares up 6% https://seekingalpha.com/news/3233404-intelgenx-inks-deal-chemo-group-to-co-develop-generic-cns-med-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3233404-intelgenx-inks-deal-chemo-group-to-co-develop-generic-cns-med-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233403\" data-ts=\"1483543958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPRT\" target=\"_blank\">WPRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233403-auto-parts-stocks-race-higher-after-gm-and-ford-impress\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto parts stocks race higher after GM and Ford impress</a></h4><ul><li>Select auto parts stocks are ripping gains after GM and Ford both top estimates with their reports on December U.S. sales.</li><li>Advancers include Westport Fuel Systems (<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='green'>+4.8%</font>), VOXX International (<a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a> <font color='green'>+4.3%</font>), Cooper-Standard Holdings (<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a> <font color='green'>+3.3%</font>), Visteon (<a href='https://seekingalpha.com/symbol/VC' title='Visteon Corporation'>VC</a> <font color='green'>+3%</font>), American Axle &amp; Manufacturing (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='green'>+1.6%</font>), Delphi Automotive (<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a> <font color='green'>+2.5%</font>), Gentherm(<a href='https://seekingalpha.com/symbol/THRM' title='Gentherm Incorporated'>THRM</a> <font color='green'>+1.8%</font>), Miller Industries (<a href='https://seekingalpha.com/symbol/MLR' title='Miller Industries Inc.'>MLR</a> <font color='green'>+0.6%</font>) and Monro Muffler Brake (<a href='https://seekingalpha.com/symbol/MNRO' title='Monro, Inc.'>MNRO</a> <font color='green'>+1%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233388-gm-gobbles-u-s-market-share\" target=\"_blank\">GM gobbles up U.S. market share</a> (Jan. 4)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233397-f-series-beast-ford-december\" target=\"_blank\">F-Series a beast for Ford in December</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3233403\" data-linked=\"Auto parts stocks race higher after GM and Ford impress\" data-tweet=\"$WPRT $WPRT $VOXX - Auto parts stocks race higher after GM and Ford impress https://seekingalpha.com/news/3233403-auto-parts-stocks-race-higher-after-gm-and-ford-impress?source=tweet\" data-url=\"https://seekingalpha.com/news/3233403-auto-parts-stocks-race-higher-after-gm-and-ford-impress\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233400\" data-ts=\"1483543358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATGFF\" target=\"_blank\">ATGFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233400-altagas-to-go-ahead-propane-export-terminal-in-b-c\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AltaGas to go ahead with propane export terminal in B.C.</a></h4><ul>     <li>AltaGas (<a href='https://seekingalpha.com/symbol/ATGFF' title='AltaGas Ltd.'>OTCPK:ATGFF</a> <font color='green'>+3.9%</font>) says it <a href=\"https://seekingalpha.com/pr/16703924-altagas-announces-positive-fid-canadas-first-west-coast-propane-export-terminal\" target=\"_blank\">will move forward</a> with construction of what would be western Canada&rsquo;s <a href=\"http://globalnews.ca/news/3158675/altagas-to-go-ahead-with-propane-terminal-in-b-c/\" target=\"_blank\">first terminal to export propane gas</a> after securing approval from federal regulators.</li><li>The $450M-$500M Ridley Island Propane Export Terminal, which would be built on First Nations&rsquo; territory near Prince Rupert, B.C., is designed to ship 1.2M metric tons/year of propane and is expected to be in service in Q1 2019.</li><li>AltaGas has a  definitive agreement to sell at least half of the exports from Ridley to a Japanese company, and is in  discussions with several buyers on further capacity commitments.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233400\" data-linked=\"AltaGas to go ahead with propane export terminal in B.C.\" data-tweet=\"$ATGFF - AltaGas to go ahead with propane export terminal in B.C. https://seekingalpha.com/news/3233400-altagas-to-go-ahead-propane-export-terminal-in-b-c?source=tweet\" data-url=\"https://seekingalpha.com/news/3233400-altagas-to-go-ahead-propane-export-terminal-in-b-c\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233398\" data-ts=\"1483543198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHT\" target=\"_blank\">AHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233398-fbr-cuts-bets-on-reits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FBR cuts bets on REITs</a></h4><ul><li>Given the potential for \"policy-driven volatility,\" the FBR team of David Corak, Jessica Levi-Ribner, and Bryan Maher turn cautious on the REIT sector (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a>, <a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a>) for H1.</li><li>In lodging, they downgrade Ashford Hospitality (<a href='https://seekingalpha.com/symbol/AHT' title='Ashford Hospitality Trust, Inc.'>AHT</a> <font color='red'>-2.8%</font>), FelCor (<a href='https://seekingalpha.com/symbol/FCH' title='FelCor Lodging Trust'>FCH</a> <font color='red'>-3.3%</font>), and Sunstone Hotel (<a href='https://seekingalpha.com/symbol/SHO' title='Sunstone Hotel Investors, Inc.'>SHO</a> <font color='red'>-0.7%</font>) to Market Perform from Outperform after they reached price targets.</li><li>In multifamily, Bluerock Residential (<a href='https://seekingalpha.com/symbol/BRG' title='Bluerock Residential Growth REIT, Inc.'>BRG</a> <font color='red'>-3.7%</font>) and Preferred Apartments (<a href='https://seekingalpha.com/symbol/APTS' title='Preferred Apartment Communities'>APTS</a> <font color='red'>-2.2%</font>) are each downgraded to Market Perform, with the analysts taking note of supply pressure.</li><li>The team's \"very cautious\" on self-storage REITs (<a href='https://seekingalpha.com/symbol/PSA' title='Public Storage'>PSA</a>, <a href='https://seekingalpha.com/symbol/LSI' title='Life Storage, Inc.'>LSI</a>, <a href='https://seekingalpha.com/symbol/CUBE' title='CubeSmart Common Shares'>CUBE</a>, <a href='https://seekingalpha.com/symbol/EXR' title='Extra Space Storage, Inc.'>EXR</a>, <a href='https://seekingalpha.com/symbol/NSA' title='National Storage Affiliates Trust'>NSA</a>, <a href='https://seekingalpha.com/symbol/SELF' title='Global Self Storage'>SELF</a>).</li><li>Not totally negative though, they are upbeat on commercial mortgages (NYSE:<a href='https://seekingalpha.com/symbol/STWD' title='Starwood Property Trust, Inc.'>STWD</a>), residential housing (NYSE:<a href='https://seekingalpha.com/symbol/SFR' title='Starwood Waypoint Homes Inc'>SFR</a>), and student housing (<a href='https://seekingalpha.com/symbol/ACC' title='American Campus Communities, Inc.'>ACC</a>, <a href='https://seekingalpha.com/symbol/EDR' title='EdR'>EDR</a>).</li><li>As for Obamacare reform, it could be 1-3 years before health care REITs see benefit. Recommended are \"private-pay-centric\" names like Senior Housing (<a href='https://seekingalpha.com/symbol/SNH' title='Senior Housing Properties Trust'>SNH</a> <font color='green'>+0.9%</font>).</li><li>Top 2017 picks include the above, along with <a href='https://seekingalpha.com/symbol/CTO' title='Consolidated-Tomoka Land Co'>CTO</a>, NSAM, <a href='https://seekingalpha.com/symbol/SIR' title='Select Income REIT'>SIR</a>.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3233398\" data-linked=\"FBR cuts bets on REITs\" data-tweet=\"$AHT $IYR $VNQ - FBR cuts bets on REITs https://seekingalpha.com/news/3233398-fbr-cuts-bets-on-reits?source=tweet\" data-url=\"https://seekingalpha.com/news/3233398-fbr-cuts-bets-on-reits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233395\" data-ts=\"1483542895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLPH\" target=\"_blank\">BLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233395-fda-oks-changes-to-bellerophons-late-stage-program-for-inopulse-in-pah-may-cut-time-to-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs changes to Bellerophon&#39;s late-stage program for INOpulse in PAH that may cut the time to market by two years; shares up 11%</a></h4><ul><li>Thinly traded nano cap Bellerophon Therapeutics (<a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='green'>+10.9%</font>) heads north on more than a 4x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/16704396-bellerophon-therapeutics-announces-fda-acceptance-modifications-inopulse-pulmonary-arterial\" target=\"_blank\">announcement </a>the FDA has accepted all its proposed modifications to the Phase 3 program for lead product candidate INOpulse for the treatment of pulmonary arterial hypertension &#40;PAH&#41;.</li><li>The new program will now consist of the ongoing INOvation-1 study and a second confirmatory withdrawal study involving 40 subjects from INOvation-1 who will cross over. The two trials will provide the data supporting a New Drug Application &#40;NDA&#41; seeking approval for INOpulse in PAH patients on long-term oxygen treatment. Since the studies can be performed in near-parallel timelines, the time to market could be shaved by as much as two years (2020).</li><li>The original Phase 3 program called for two one-year studies, INOvation-1 and INOvation-2, that implied a likely FDA approval date in 2022.</li><li><a href=\"http://www.bellerophon.com/pipeline/inopulse-technology\" target=\"_blank\">INOpulse&nbsp;</a>is a drug-device combination system that delivers pulsed doses of nitric oxide. It is portable, suitable for at-home use and automatically adjusts to the patient's breathing patterns to deliver consistent dosing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233395\" data-linked=\"FDA OKs changes to Bellerophon&#39;s late-stage program for INOpulse in PAH that may cut the time to market by two years; shares up 11%\" data-tweet=\"$BLPH - FDA OKs changes to Bellerophon&#39;s late-stage program for INOpulse in PAH that may cut the time to market by two years; shares up 11% https://seekingalpha.com/news/3233395-fda-oks-changes-to-bellerophons-late-stage-program-for-inopulse-in-pah-may-cut-time-to-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3233395-fda-oks-changes-to-bellerophons-late-stage-program-for-inopulse-in-pah-may-cut-time-to-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233387\" data-ts=\"1483541231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIE\" target=\"_blank\">CIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233387-cobalt-energy-finds-encouraging-results-north-platte-appraisal-well\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cobalt Energy finds encouraging results at North Platte appraisal well</a></h4><ul>     <li>Cobalt Energy (<a href='https://seekingalpha.com/symbol/CIE' title='Cobalt International Energy, Inc.'>CIE</a> <font color='green'>+2.7%</font>) opens higher after saying its latest Gulf of Mexico appraisal well turned up <a href=\"https://seekingalpha.com/pr/16704135-cobalt-international-energy-inc-announces-preliminary-appraisal-well-results-north-platte\" target=\"_blank\">encouraging indications of oil</a>.</li>     <li>CIE says the North Platte #4 appraisal well encountered 650 feet of net oil pay, greater than  the 550 feet of net pay found in the North Platte #3 appraisal  well, and initial results also indicate high quality reservoirs on the eastern flank of the North Platte field.</li>     <li>CIE is operator and owns a 60% working interest in North Platte, and Total (<a href='https://seekingalpha.com/symbol/TOT' title='TOTAL S.A.'>TOT</a> <font color='green'>+0.3%</font>) owns the remaining 40%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233387\" data-linked=\"Cobalt Energy finds encouraging results at North Platte appraisal well\" data-tweet=\"$CIE $CIE $TOT - Cobalt Energy finds encouraging results at North Platte appraisal well https://seekingalpha.com/news/3233387-cobalt-energy-finds-encouraging-results-north-platte-appraisal-well?source=tweet\" data-url=\"https://seekingalpha.com/news/3233387-cobalt-energy-finds-encouraging-results-north-platte-appraisal-well\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233384\" data-ts=\"1483541153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOK\" target=\"_blank\">EVOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233384-evoke-pharma-mines-data-from-failed-late-stage-study-of-gimoti-in-diabetic-gastroparesis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evoke Pharma mines data from failed late-stage study of Gimoti in diabetic gastroparesis; valid treatment effect in subset of patients; shares up 47%</a></h4><ul><li>Nano cap Evoke Pharma (<a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='green'>+46.9%</font>) jumps out of the blocks on increased volume in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1403708/000119312517001260/d303152d8k.htm\" target=\"_blank\">announcement </a>that parsing the data from its failed Phase 3 study assessing Gimoti, its nasal delivery formulation of metoclopramide for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adult women, identified a statistically significant treatment effect in patients with moderate-to-severe symptoms (n=105/205). Gimoti was superior to placebo in both the Intent-to-Treat (n=105) and Per Protocol (n=78) populations.</li><li>The company adds that clinically and statistically significant improvements in nausea and abdominal pain compared to placebo were also demonstrated.</li><li>Evoke says the major reason the study failed its overall efficacy endpoint was the inclusion of patients with mild symptoms.</li><li>Shares jumped last month after the company reported guidance from the FDA that supported focusing on patients with more severe symptoms. The company plans to submit an NDA under the accelerated 505(b)(2) pathway which allows the inclusion of data from studies performed by others.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3231133-evoke-pharma-jumps-38-percent-improved-prospects-gimoti\" target=\"_blank\">Evoke Pharma jumps 38% on improved prospects for Gimoti</a> (Dec. 16, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3233384\" data-linked=\"Evoke Pharma mines data from failed late-stage study of Gimoti in diabetic gastroparesis; valid treatment effect in subset of patients; shares up 47%\" data-tweet=\"$EVOK - Evoke Pharma mines data from failed late-stage study of Gimoti in diabetic gastroparesis; valid treatment effect in subset of patients; shares up 47% https://seekingalpha.com/news/3233384-evoke-pharma-mines-data-from-failed-late-stage-study-of-gimoti-in-diabetic-gastroparesis?source=tweet\" data-url=\"https://seekingalpha.com/news/3233384-evoke-pharma-mines-data-from-failed-late-stage-study-of-gimoti-in-diabetic-gastroparesis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233378\" data-ts=\"1483540191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233378-tesla-motors-in-spotlight-after-deliveries-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors in the spotlight after deliveries update</a></h4><ul> <li>Tesla Motors (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) added to the debate fodder yesterday with its <a href=\"https://seekingalpha.com/news/3233230-tesla-motors-misses-2016-delivery-guidance\" target=\"_blank\">update</a> on deliveries and production run rates.</li> <li>Guggenheim: No fear from analyst Robert Cihra, who jumped over from Sterne Agee CRT, as he initiates Tesla at Buy with a price target of $280.</li> <li>Cowen: The investment firm sticks with a bearish view (Underperform/$155 PT) as it notes the switch away from Mobileye took a toll on the production rate in Fremont.</li> <li>Consumer Edge: Take the long view on Tesla, advises the boutique firm. 4K units slipping from one quarter to the next is seen as having little bearing on the long-term story. Shares are rated at Overweight with a $255 PT.</li> <li>Baird: The firm continues to see strong demand sustaining into the Model 3 production ramp. Analyst Ben Kallo stays positive (Outperform/$338PT).</li> <li><a href=\"https://seekingalpha.com/symbol-jq/TSLA/focus\" target=\"_blank\">Seeking Alpha</a>: Montana Skeptic, Bill Maurer, Paulo Santos and Randall Radic all have fresh takes on the Tesla conundrum.</li><li>Sources: Bloomberg and MarketBeat.com</li><li>TSLA <font color='red'>-1.49%</font> premarket to $213.75 as they test their 200-DMA.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233378\" data-linked=\"Tesla Motors in the spotlight after deliveries update\" data-tweet=\"$TSLA - Tesla Motors in the spotlight after deliveries update https://seekingalpha.com/news/3233378-tesla-motors-in-spotlight-after-deliveries-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3233378-tesla-motors-in-spotlight-after-deliveries-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233371\" data-ts=\"1483539683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233371-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='green'>+48%</font>. <a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+42%</font>. NVLS <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a> <font color='green'>+7%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a> <font color='red'>-61%</font>. <a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3233371\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$EVOK $CBAY $ALPN - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3233371-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3233371-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233369\" data-ts=\"1483539299\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STM\" target=\"_blank\">STM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233369-morgan-stanley-downgrades-stmicroelectronics-to-underweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley downgrades STMicroelectronics to Underweight</a></h4><ul><li>Citing what the firm views as an overdone rally, <a href=\"http://www.streetinsider.com/Analyst+Comments/STMicroelectronics+%28STM%29+Falls+as+Morgan+Stanley+Cuts+To+Underweight/12388287.html\" target=\"_blank\">analyst Francois Meunier</a> moves from Equal Weight while raising target from &euro;5.25 to &euro;7. Considers main investor focus to be on discerning whether recent sales strength is attributable to structural improvements or cycle tailwinds, both of which firm sees indicators of, though not enough so to issue confidence based on current valuation.</li><li>STMicroelectronics (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>) ADRs&nbsp;<font color='red'>-2.19%</font>&nbsp;pre-market to $10.74.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233369\" data-linked=\"Morgan Stanley downgrades STMicroelectronics to Underweight\" data-tweet=\"$STM - Morgan Stanley downgrades STMicroelectronics to Underweight https://seekingalpha.com/news/3233369-morgan-stanley-downgrades-stmicroelectronics-to-underweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3233369-morgan-stanley-downgrades-stmicroelectronics-to-underweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233366\" data-ts=\"1483538638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALPN\" target=\"_blank\">ALPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233366-nivalis-exploring-strategic-alternatives-shares-perk-up-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nivalis exploring strategic alternatives; shares perk up 7% premarket</a></h4><ul><li>Thinly traded nano cap Nivalis Therapeutics (NVLS) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on increased volume. After the close yesterday, it <a href=\"https://seekingalpha.com/pr/16703944-nivalis-therapeutics-announces-review-strategic-alternatives\" target=\"_blank\">announced </a>that the board has initiated a process to \"explore and review a range of strategic alternatives\" to boost shareholder value.</li><li>Ladenburg Thalmann is advising.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233366\" data-linked=\"Nivalis exploring strategic alternatives; shares perk up 7% premarket\" data-tweet=\"$ALPN - Nivalis exploring strategic alternatives; shares perk up 7% premarket https://seekingalpha.com/news/3233366-nivalis-exploring-strategic-alternatives-shares-perk-up-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3233366-nivalis-exploring-strategic-alternatives-shares-perk-up-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233364\" data-ts=\"1483538630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REXX\" target=\"_blank\">REXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233364-rex-energy-sells-utica-warrior-south-assets-to-antero-resources-for-30m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rex Energy sells Utica Warrior South assets to Antero Resources for $30M</a></h4><ul><li>Rex Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a>) <font color='green'>+4.4%</font> premarket after Antero Resources (NYSE:<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a>) <a href=\"https://seekingalpha.com/pr/16704205-rex-energy-announces-sale-ohio-utica-warrior-south-asset\" target=\"_blank\">agrees to acquire</a> its Ohio Utica assets in the Warrior  South Area for $30M.</li><li>Rex says the assets, which include 4,100 net acres and 14 gross wells currently producing ~9M cfe/day, are non-core and were not included in its future development plans.</li><li>Upon closing of the sale, Rex says it has received approval  from its bank lenders to maintain the existing $190M borrowing base  under its revolving credit facility.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233364\" data-linked=\"Rex Energy sells Utica Warrior South assets to Antero Resources for $30M\" data-tweet=\"$REXX $REXX $AR - Rex Energy sells Utica Warrior South assets to Antero Resources for $30M https://seekingalpha.com/news/3233364-rex-energy-sells-utica-warrior-south-assets-to-antero-resources-for-30m?source=tweet\" data-url=\"https://seekingalpha.com/news/3233364-rex-energy-sells-utica-warrior-south-assets-to-antero-resources-for-30m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233359\" data-ts=\"1483538264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233359-jpmorgan-likes-global-blood-therapeutics-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan likes Global Blood Therapeutics; shares ahead 7% premarket</a></h4><ul><li>Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a>) perks up&nbsp;<font color='green'>7%</font>&nbsp;premarket on modest volume on the heels of JPMorgan's initiation of coverage with an Overweight rating and $25 (64% upside) price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233359\" data-linked=\"JPMorgan likes Global Blood Therapeutics; shares ahead 7% premarket\" data-tweet=\"$GBT - JPMorgan likes Global Blood Therapeutics; shares ahead 7% premarket https://seekingalpha.com/news/3233359-jpmorgan-likes-global-blood-therapeutics-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3233359-jpmorgan-likes-global-blood-therapeutics-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233354\" data-ts=\"1483537904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCUL\" target=\"_blank\">OCUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233354-ocular-announces-positive-study-data-for-dextenza-shares-ahead-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocular announces more positive study data for Dextenza; shares ahead 9% premarket</a></h4><ul><li>Micro cap Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a>) perks up<font color='green'> 9%</font>&nbsp;premarket on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16704377-ocular-therapeutix-announces-additional-successful-results-phase-3-clinical-trial-dextenza\" target=\"_blank\">announcement</a> of additional data from its Phase 3 study assessing DEXTENZA (dexamethasone insert) 0.4 mg for the treatment of post-surgical ocular inflammation and pain. The company initially reported successful results in November.</li><li>DEXTENZA met a secondary endpoint of demonstrating superiority to placebo at all measured time points in an indicator of inflammation called anterior chamber &#40;AC&#41; flare. Specifically, ~46% of the treatment group showed an absence of <a href=\"http://www.rootatlas.com/wordpress/video/561/cell-and-flare-in-the-eye-video/\" target=\"_blank\">AC flare</a> at day 4 after insertion. Statistically significant differences in AC flare compared to placebo were observed on days 4, 14 and 30 post insertion. The difference at day 2 fell short of statistical significance.</li><li>The company is working through a CRL it received in July from the FDA in response to its marketing application.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3224112-ocular-therapeutixs-dextenza-successful-late-stage-study-post-surgical-ocular-inflammation\" target=\"_blank\">Ocular Therapeutix's Dextenza successful in late-stage study in post-surgical ocular inflammation and pain; shares ahead 24% premarket</a> (Nov. 14, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3233354\" data-linked=\"Ocular announces more positive study data for Dextenza; shares ahead 9% premarket\" data-tweet=\"$OCUL - Ocular announces more positive study data for Dextenza; shares ahead 9% premarket https://seekingalpha.com/news/3233354-ocular-announces-positive-study-data-for-dextenza-shares-ahead-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3233354-ocular-announces-positive-study-data-for-dextenza-shares-ahead-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233339\" data-ts=\"1483535993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233339-piper-cuts-uninvestable-valeant-price-target-to-11-shares-ease-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper cuts &quot;uninvestable&quot; Valeant price target to $11, shares ease 2% premarket</a></h4><ul><li>Beleaguered Valeant Pharmaceuticals (VRX) slumps&nbsp;<font color='red'>2%</font>&nbsp;premarket on average volume on the heels of bearish comments from Piper Jaffray's David Amsellem. He regards the company as \"univestable\" citing prescription volume headwinds and slowing sales of dermatology products Elidel and Solodyn ahead of generic competition in 2018 and 2019. He adds that the looming erosion of its U.S. Diversified Products business due to generics \"remains the most alarming aspect of the base business.\"</li><li>He maintains his Underweight (Sell) rating and lowers the fair value target to $11 (27% downside risk) from $16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233339\" data-linked=\"Piper cuts &quot;uninvestable&quot; Valeant price target to $11, shares ease 2% premarket\" data-tweet=\"$BHC - Piper cuts &quot;uninvestable&quot; Valeant price target to $11, shares ease 2% premarket https://seekingalpha.com/news/3233339-piper-cuts-uninvestable-valeant-price-target-to-11-shares-ease-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3233339-piper-cuts-uninvestable-valeant-price-target-to-11-shares-ease-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>106&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233336\" data-ts=\"1483535787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNF\" target=\"_blank\">UNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233336-on-unifirsts-fq1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on UniFirst&#39;s FQ1</a></h4><ul>     <li>Unifirst (NYSE:<a href='https://seekingalpha.com/symbol/UNF' title='UniFirst Corp.'>UNF</a>)&nbsp;reports&nbsp;Core Laundry revenue rose 5% to $351.84M in <a href=\"https://seekingalpha.com/pr/16704381-unifirst-announces-financial-results-first-quarter-fiscal-2017\" target=\"_blank\">FQ1</a>.</li>     <li>Specialty Garments segment revenue squeezed 16.5% to $22.36M</li>     <li>First Aid segment revenue grew 2.9% to $11.91M.</li>     <li>Gross margin rate declined 222 bps to 38.16%.</li>     <li>Operating margin rate down 376 bps to 11.85%.</li>     <li>Segment earnings: Core Laundry operations: $43.67M (-17.6%);&nbsp;Specialty Garment: $1.15M (-73.1%);&nbsp;First Aid: $0.93M (-10%).</li>     <li><b>FY2017 Guidance</b>:&nbsp;Revenues: $1.550B to $1.565B; Diluted EPS: $4.85 to $5.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233336\" data-linked=\"More on UniFirst&#39;s FQ1\" data-tweet=\"$UNF - More on UniFirst&#39;s FQ1 https://seekingalpha.com/news/3233336-on-unifirsts-fq1?source=tweet\" data-url=\"https://seekingalpha.com/news/3233336-on-unifirsts-fq1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233327\" data-ts=\"1483535342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233327-redhill-biopharma-to-present-results-of-first-late-stage-study-of-rhbminus-105-for-h-pylori\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill Biopharma to present results of the first late-stage study of RHB-105 for H. pylori infection on Friday; shares up 2% premarket</a></h4><ul> <li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) <a href=\"https://seekingalpha.com/pr/16704193-redhill-biopharma-present-positive-results-first-phase-iii-study-rhbminus-105-h-pylori\" target=\"_blank\">announces</a> that Medical Director Ira Kalfus, M.D., will present the positive final results of the first Phase 3 study, ERADICATE, of <a href=\"http://www.redhillbio.com/rhb-105\" target=\"_blank\">RHB-105</a> for the treatment of&nbsp;<a href=\"https://medlineplus.gov/helicobacterpyloriinfections.html\" target=\"_blank\">H. pylori&nbsp;infection</a>, at the Innovations in Gastroenterology 2017 Symposium, on Friday, January 6 at 10:15 AM IST, at the Hilton Hotel, Tel Aviv, Israel.</li>     <li>ERADICATE successfully met its primary endpoint of superiority by demonstrating&nbsp;89.4% efficacy&nbsp;over historical standard-of-care eradication&nbsp;which showed only 63% eradication rate. A confirmatory Phase 3 study will be initiated in H1.</li><li>RHB-105 is fixed dose combination of two antibiotics and a&nbsp;<a href=\"https://en.wikipedia.org/wiki/Proton-pump_inhibitor\" target=\"_blank\">proton pump inhibitor</a>&nbsp;&#40;PPI&#41;&nbsp;in an all-in-one orally administered capsule. A PPI reduces the stomach's production of gastric acid.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3233327\" data-linked=\"RedHill Biopharma to present results of the first late-stage study of RHB-105 for H. pylori infection on Friday; shares up 2% premarket\" data-tweet=\"$RDHL - RedHill Biopharma to present results of the first late-stage study of RHB-105 for H. pylori infection on Friday; shares up 2% premarket https://seekingalpha.com/news/3233327-redhill-biopharma-to-present-results-of-first-late-stage-study-of-rhbminus-105-for-h-pylori?source=tweet\" data-url=\"https://seekingalpha.com/news/3233327-redhill-biopharma-to-present-results-of-first-late-stage-study-of-rhbminus-105-for-h-pylori\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233335\" data-ts=\"1483535300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECA\" target=\"_blank\">ECA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233335-encana-raises-2017-production-growth-margin-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Encana raises 2017 production growth, margin forecast</a></h4><ul><li>Encana (NYSE:<a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a>) <font color='green'>+5.6%</font> premarket after saying it expects 2017 production growth from its core assets to come in at the upper range of or surpass its previously  indicated growth plan of 15%-20% Y/Y.</li><li>ECA now expects to deliver a corporate margin above $10/boe in  2017 vs. an anticipated $8/boe outlined during its investor day in October.</li><li>ECA says it plans to finalize its 2017 budget and issue guidance along with its Q4 2016 and year-end results on Feb. 16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233335\" data-linked=\"Encana raises 2017 production growth, margin forecast\" data-tweet=\"$ECA - Encana raises 2017 production growth, margin forecast https://seekingalpha.com/news/3233335-encana-raises-2017-production-growth-margin-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3233335-encana-raises-2017-production-growth-margin-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233318\" data-ts=\"1483532715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233318-baml-sizes-up-altria-and-philip-morris\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML sizes up Altria and Philip Morris</a></h4><ul> <li>Bank of America Merrill Lynch dissects the impact of new tax policies on tobacco stocks.</li> <li>The investment firm boosts Altria (NYSE:<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a>) to a Buy rating and lifts its price target to $75. The company's effective tax rate could improve significantly under proposals from either President-elect Donald Trump (15%) proposal or Speaker Paul Ryan (20%).</li> <li>Philip Morris (NYSE:<a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a>) is downgraded to Neutral from Buy due to concerns over the strong U.S. dollar and a less significant impact from new U.S. tax policies. BAML's price target on Philip Morris is lowered to $96 from $102.</li> <li>Source: Bloomberg</li> <li>MO <font color='green'>+1.18%</font> premarket to $68.43. PM <font color='red'>-1.02%</font> to $90.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3233318\" data-linked=\"BAML sizes up Altria and Philip Morris\" data-tweet=\"$MO $MO $PM - BAML sizes up Altria and Philip Morris https://seekingalpha.com/news/3233318-baml-sizes-up-altria-and-philip-morris?source=tweet\" data-url=\"https://seekingalpha.com/news/3233318-baml-sizes-up-altria-and-philip-morris\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233311\" data-ts=\"1483531641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233311-baml-turns-bullish-on-constellation-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML turns bullish on Constellation Brands</a></h4><ul> <li>Bank of America Merrill Lynch lifts Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) to a Buy rating after having the beverage stock set at Neutral.</li> <li>The investment firm assigns a price target of $175 to Constellation.</li> <li>STZ <font color='green'>+1.94%</font> premarket to $157.75.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3233311\" data-linked=\"BAML turns bullish on Constellation Brands\" data-tweet=\"$STZ - BAML turns bullish on Constellation Brands https://seekingalpha.com/news/3233311-baml-turns-bullish-on-constellation-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3233311-baml-turns-bullish-on-constellation-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3233278\" data-ts=\"1483514830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOSYY\" target=\"_blank\">TOSYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3233278-toshiba-hit-fresh-scandal-allegations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toshiba hit by fresh scandal allegations</a></h4><ul><li>Toshiba (<a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) shares <font color='red'>fell more than 5%</font> in early trade following <a href=\"http://www.cnbc.com/2017/01/03/toshiba-shares-fall-on-media-report-of-profit-padding.html\" target=\"_blank\">reports</a> that Japan's securities watchdog suspected the conglomerate of misreporting profits by &yen;40B ($340M) over three years.</li><li>The revelations add to a series of accounting troubles swirling around Toshiba, which was downgraded by ratings agencies last week after it admitted it may face a multi-billion dollar writedown over its U.S. nuclear business.</li></ul><div class=\"tiny-share-widget\" data-id=\"3233278\" data-linked=\"Toshiba hit by fresh scandal allegations\" data-tweet=\"$TOSYY $TOSBF - Toshiba hit by fresh scandal allegations https://seekingalpha.com/news/3233278-toshiba-hit-fresh-scandal-allegations?source=tweet\" data-url=\"https://seekingalpha.com/news/3233278-toshiba-hit-fresh-scandal-allegations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":69,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}